Sun Pharma Update by Epic Research

Sun Pharma and Merck sign exclusive drug licensing agreement



Sun Pharma, Merck agreement for Merck’s skin ailment drug Tildrakizumab



Sun Pharma to pay USD 80 million for worldwide rights for Merck’s drug



Sun Pharma to fund development and regulatory activities for Tildrakizumab



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips